Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-246.06%
operating margin TTM
-264.15%
revenue TTM
22.30 Million
revenue per share TTM
0.9$
valuation ratios | |
|---|---|
| pe ratio | -0.77 |
| peg ratio | -0.13 |
| price to book ratio | 0.69 |
| price to sales ratio | 1.88 |
| enterprise value multiple | -1.25 |
| price fair value | 0.69 |
profitability ratios | |
|---|---|
| gross profit margin | 87.39% |
| operating profit margin | -264.15% |
| pretax profit margin | -246.06% |
| net profit margin | -246.06% |
| return on assets | -71.98% |
| return on equity | -71.87% |
| return on capital employed | -94.76% |
liquidity ratio | |
|---|---|
| current ratio | 4.89 |
| quick ratio | 4.54 |
| cash ratio | 1.93 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 631.39 |
| operating cycle | 726.61 |
| days of payables outstanding | 158.66 |
| cash conversion cycle | 567.95 |
| receivables turnover | 3.83 |
| payables turnover | 2.30 |
| inventory turnover | 0.58 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | -313.85 |
| cash flow to debt ratio | -64.70 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.47 |
| cash per share | 2.53 |
| operating cash flow per share | -2.47 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -64.70 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -360.02 |
Frequently Asked Questions
When was the last time Aadi Bioscience, Inc. (NASDAQ:AADI) reported earnings?
Aadi Bioscience, Inc. (AADI) published its most recent earnings results on 06-11-2024.
What is Aadi Bioscience, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Aadi Bioscience, Inc. (NASDAQ:AADI)'s trailing twelve months ROE is -71.87%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Aadi Bioscience, Inc. (AADI) currently has a ROA of -71.98%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AADI's net profit margin stand at?
AADI reported a profit margin of -246.06% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AADI's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.89 in the most recent quarter. The quick ratio stood at 4.54, with a Debt/Eq ratio of 0.01.